Raju Prasad - Net Worth and Insider Trading

Raju Prasad Net Worth

The estimated net worth of Raju Prasad is at least $784,360 dollars as of 2025-06-24. Raju Prasad is the CFO of CRISPR Therapeutics AG and owns about 16,767 shares of CRISPR Therapeutics AG (CRSP) stock worth over $784,360. Details can be seen in Raju Prasad's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raju Prasad has not made any transactions after 2025-03-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Raju Prasad

To

Raju Prasad Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Raju Prasad owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .

Click here to see the complete history of Raju Prasad’s form 4 insider trades.

Insider Ownership Summary of Raju Prasad

Ticker Company Transaction Date Type of Owner
CRSP CRISPR Therapeutics AG 2025-03-21 Chief Financial Officer

Raju Prasad Latest Holdings Summary

Raju Prasad currently owns a total of 1 stock. Raju Prasad owns 16,767 shares of CRISPR Therapeutics AG (CRSP) as of March 21, 2025, with a value of $784,360.

Latest Holdings of Raju Prasad

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRSP CRISPR Therapeutics AG 2025-03-21 16,767 46.78 784,360

Holding Weightings of Raju Prasad


Raju Prasad Form 4 Trading Tracker

According to the SEC Form 4 filings, Raju Prasad has made a total of 3 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 2,197 shares on March 21, 2025, which brought Raju Prasad around $90,582.

Insider Trading History of Raju Prasad

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Raju Prasad Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Raju Prasad Ownership Network

Ownership Network List of Raju Prasad

No Data

Ownership Network Relation of Raju Prasad

Insider Network Chart


Raju Prasad Owned Company Details

What does CRISPR Therapeutics AG do?

Who are the key executives at CRISPR Therapeutics AG?

Raju Prasad is the Chief Financial Officer of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include General Counsel and Secretary James R. Kasinger , Chief Business Officer Samarth Kulkarni , and Chief Medical Officer Phuong Khanh Morrow .

CRISPR Therapeutics AG (CRSP) Insider Trades Summary

Over the past 18 months, Raju Prasad made 3 insider transaction in CRISPR Therapeutics AG (CRSP) with a net sale of 9,483. Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 261,024 shares made by Samarth Kulkarni , a net sale of 25,642 shares made by James R. Kasinger , and a net sale of 3,932 shares made by .

In summary, during the past 3 months, insiders sold 3,932 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 3,932 shares. During the past 18 months, 306,882 shares of CRISPR Therapeutics AG (CRSP) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 299,882 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CRISPR Therapeutics AG Insider Transactions

No Available Data

Raju Prasad Mailing Address

Above is the net worth, insider trading, and ownership report for Raju Prasad. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Raju Prasad's mailing address is: Boston Ma 02127.